If approved, levacetylleucine could become the first therapy on the market for ataxia-telangiectasia.

Background and objective: Childhood, adolescence, and emerging adulthood represent critical transitional periods characterized by rapid biological, psychological, and social development, each of which ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the submission of its clinical trial application (CTA) for Study SRP-1005-101, ...

With schools opening back up after the festive break, the NHS has issued a warning to parents for when they need to keep their children at home. This comes after cases of flu skyrocketed across the UK ...

The 2025-2026 flu season is surging in the U.S. and New Jersey, where there's been increased severity of influenza A, with further testing from the CDC showing many NJ residents have the emerging ...

Health officials are warning about a surge in so-called “super flu” cases as a particularly aggressive strain drives higher-than-usual hospitalizations this season. Patients are reporting intense ...